Abstract:Hormonal contraceptives have been introduced more than 60 years ago and have since been subject to one controversy after the other. Current debates center around the question of mental health implications of hormonal contraceptives with some studies suggesting adverse mood effects in 4-10% of women, while other studies highlight mood stabilizing effects in hormonal contraceptive users. Mood changes during hormonal contraceptive use are among the most common reasons for discontinuation of hormonal contraceptive treatment. Interestingly, subjective reports of mental health changes, both positive and negative, have been available since the beginnings of hormonal contraception, while research on the potential effects of hormonal contraception on the brain has only started a decade ago. Accordingly, little is known about the neurobiological underpinnings of hormonal contraceptive effects on mood. In this symposium we highlight this controversy from the perspective of women’s health research across various hormonal transition periods, like the menstrual cycle, the postpartum period and menopause, which have (i) all been associated with brain changes and (ii) have all demonstrated individual differences between women with higher and lower psychological sensitivity to hormonal fluctuations. The female brain is remarkably flexible in adapting to hormonal changes at a rapid timescale and hormonal contraceptives are no exception in this regard. However, it is of utmost importance to understand how different neuronal systems respond to different hormonal combinations in different populations of women. We here present the most current research findings on hormonal contraceptive actions on the brain and women’s mental health, ranging from alterations in resting state networks, over molecular signatures of hormone sensitivity to alterations in stress responsivity. The presented studies use different designs of contraceptive treatment/withdrawal and focus on different sub-populations of women, highlighting the importance of individualized approaches to hormonal contraception and mental health, thereby carving out a future perspective for the neuroscience of hormonal contraception. Going forward, the most pressing issue appears to be the identification of biomarkers for risk and protective factors predisposing women to develop adverse or beneficial mood symptoms during hormonal contraception.

- Association of hormonal contraception with stress reactivity in women

Reduced threat avoidance but increased stress induced approach bias in women taking oral contraceptives

The levonorgestrel-releasing intrauterine device is related to early emotional reactivity: an ERP study

Hormonal Cycle and Contraceptive Effects on Amygdala and Salience Resting-State Networks in Women with Previous Affective Side Effects on the Pill

The Influence of Menstrual Cycle and Androstadienone on Female Stress Reactions: An fMRI Study

Emotion and birth control: Emotion regulation ERPs differ based on menstrual cycle phase and hormonal contraceptive use

Effects of Hormonal Contraceptives on Mood: A Focus on Emotion Recognition and Reactivity, Reward Processing, and Stress Response

Role of Hormonal Change after Start and Discontinuation of the Pill in Women’s Functional Brain Architecture and Mental Health

The link between daily affective complexity and anxiety is altered by oral contraceptive use

Altered psychobiological responsiveness in women with irritable bowel syndrome

Hormonal contraceptive exposure relates to changes in resting state functional connectivity of anterior cingulate cortex and amygdala

Hormonal Contraceptives and the Brain - Implications for Women's Mental Health

Psychological stress and cortisol during pregnancy: An ecological momentary assessment (EMA)-Based within- and between-person analysis

Sexual function and metabolic/hormonal changes in women using long-term hormonal and non-hormonal contraceptives: a pilot study

Oral contraceptive use changes brain activity and mood in women with previous negative affect on the pill—A double-blinded, placebo-controlled randomized trial of a levonorgestrel-containing combined oral contraceptive

The effect of cognitive reappraisal and early-life maternal care on neuroendocrine stress responses

Sex and stress: Men and women show different cortisol responses to psychological stress induced by the Trier social stress test and the Iowa singing social stress test

Impact of endogenous and exogenous progesterone exposure on stress biomarkers: a systematic review

Effect of stress on ovulatory function

Stress, mood, and cortisol during daily life in women with Premenstrual Dysphoric Disorder (PMDD)

Molecular brain signatures of oral contraceptives and implications for risk for depressive episodes